Akiram Therapeutics, a Swedish biotech company specializing in targeted radiotherapy, today announces that the first patient has been enrolled in the Phase 1 clinical trial of its drug candidate 177Lu ...

Following MHRA approval, Stablepharma Ltd has commenced a Phase 1 clinical trial with its lead candidate, fridge-free tetanus and diphtheria vaccine, SPVX02. The Phase 1, first-in-human clinical trial ...

Experts emphasize the need for enhanced clinical trial infrastructure in community oncology to ensure equitable access to ...

The upcoming 12th Annual Clinical Trials in Oncology conference will cover a wide range of topics on clinical research in ...

2025 (UTC-7), impressive results of the Phase 3 clinical trial (NCT05737160) evaluating the efficacy and safety of Telitacicept (synonym: RC18; brand name: 泰爱®) in patients with generalized ...

Lilly plans to submit orforglipron for approval in weight management by the end of 2025, with a T2D application to follow in ...

“Once a cell’s role is determined, it rarely changes to another type,” explains ... Potential treatments must pass through several phases of clinical trials before being approved, a process ...

Discover why BTK inhibitors have attracted interest for treating multiple sclerosis, as a few late-stage candidates close in ...

Following the news of two lecanemab-related deaths reported on the eve of the Clinical ... anticipated phase 3 trial of gantenerumab in early Alzheimer’s disease, in yet another setback for ...

There are different reasons why head-to-head trials are so rare. For one, it takes more time to run head-to-head clinical trials. Another hindrance ... on a series of phase-3 studies which were ...

With more than 40% of U.S. adults having been diagnosed with liver disease, Virginia Commonwealth University (VCU) research suggests that there might be a way to treat fatty liver disease.